Bevacizumab in retinal vein occlusion-results of a prospective case series

被引：0
|
作者：
Andreas Stahl
Hansjürgen Agostini
Lutz L. Hansen
Nicolas Feltgen
机构：
[1] University of Freiburg,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Bevacizumab; Avastin; Retinal vein occlusion; Macular edema; Intravitreal injection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1429 / 1436
页数：7
相关论文
共 50 条
  • [1] Bevacizumab in retinal vein occlusion-results of a prospective case series
    Stahl, Andreas
    Agostini, Hansjuergen
    Hansen, Lutz L.
    Feltgen, Nicolas
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) : 1429 - 1436
  • [2] Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
    Hall, Leangelo
    Frizzera, Luma Paiva
    Coelho, Laura Fernandes
    Carricondo, Pedro Carlos
    Oyamada, Maria Kiyoko
    Pimentel, Sergio Luis Gianotti
    Abalem, Maria Fernanda
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2019, 5 (01) : 1 - 8
  • [3] The treatment of branch retinal vein occlusion with bevacizumab
    Badala, Federico
    CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 234 - 238
  • [4] Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion
    Parajuli, Anil
    Joshi, Purushottam
    Subedi, Prabha
    Pradhan, Chandni
    NEPALESE JOURNAL OF OPHTHALMOLOGY, 2020, 12 (02) : 281 - 289
  • [5] Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
    Leangelo Hall
    Luma Paiva Frizzera
    Laura Fernandes Coelho
    Pedro Carlos Carricondo
    Maria Kiyoko Oyamada
    Sergio Luis Gianotti Pimentel
    Maria Fernanda Abalem
    International Journal of Retina and Vitreous, 5
  • [6] Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion
    Ach, Thomas
    Hoeh, Alexandra E.
    Schaal, Karen B.
    Scheuerle, Alexander F.
    Dithmar, Stefan
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) : 155 - 159
  • [7] Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial
    Algvere, Peep V.
    Epstein, David
    von Wendt, Gunvor
    Seregard, Stefan
    Kvanta, Anders
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (06) : 789 - 795
  • [8] Intravitreal bevacizumab (Avastin) in central retinal vein occlusion
    Hsu, Jason
    Kaiser, Richard S.
    Sivalingam, Arunan
    Abraham, Prema
    Fineman, Mitchell S.
    Samuel, Michael A.
    Vander, James F.
    Regillo, Carl D.
    Ho, Allen C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (08): : 1013 - 1019
  • [9] Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study
    Rosner, Ann K.
    Closs, Ellen I.
    Habermeier, Alice
    Gericke, Adrian
    Binder, Harald
    Scharrer, Inge
    Pfeiffer, Norbert
    Ponto, Katharina A.
    OPHTHALMOLOGE, 2021, 118 (07): : 684 - 690
  • [10] Intravitreal bevacizumab injections for treatment of central retinal vein occlusion - Six-month results of a prospective trial
    Priglinger, Siegfried G.
    Wolf, Armin H.
    Kreutzer, Thomas C.
    Kook, Daniel
    Hofer, Anja
    Strauss, Rupert W.
    Alge, Claudia S.
    Kunze, Christian
    Haritoglou, Christos
    Kampik, Anselm
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (08): : 1004 - 1012
12345